{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:23:47Z","timestamp":1791527027510,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Coronavirus disease 2019 (COVID-19) often causes atypical clinical manifestations similar to other infectious diseases. In malaria-endemic areas, the pandemic situation will very likely result in co-infection of COVID-19 and malaria, although reports to date are still few. Meanwhile, this disease will be challenging to diagnose in areas with low malaria prevalence because the symptoms closely resemble COVID-19.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 23-year-old male patient presented to the hospital with fever, anosmia, headache, and nausea 1\u00a0week before. He was diagnosed with COVID-19 and treated for approximately 10\u00a0days, then discharged to continue self-quarantine at home. 2\u00a0weeks later, he returned to the hospital with a fever raised intermittently every 2\u00a0days and marked by a chilling-fever-sweating cycle. A laboratory test for malaria and a nasopharyngeal swab for SARS CoV-2 PCR were conducted, confirming both diagnoses. The laboratory examination showed markedly elevated D-dimer. He was treated with dihydroartemisinin-piperaquine (DHP) 4 tablets per day for 3\u00a0days and primaquine 2 tablets per day for 14\u00a0days according to Indonesian National Anti-malarial Treatment Guidelines. After 6\u00a0days of treatment, the patient had no complaints, and the results of laboratory tests had improved. This report describes the key points in considering the differential diagnosis and prompt treatment of malaria infection during the pandemic of COVID-19 in an endemic country to prevent the worse clinical outcomes. COVID-19 and malaria may also cause a hypercoagulable state, so a co-infection of those diseases may impact the prognosis of the disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This case report shows that considering the possibility of a co-infection in a COVID-19 patient who presents with fever can prevent delayed treatment that can worsen the disease outcome. Paying more attention to a history of travel to malaria-endemic areas, a history of previous malaria infection, and exploring anamnesis regarding the fever patterns in patients are important points in making a differential diagnosis of malaria infection during the COVID-19 pandemic.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12936-022-04215-5","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T14:03:36Z","timestamp":1655993016000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prolonged fever and exaggerated hypercoagulopathy in malaria vivax relapse and COVID-19 co-infection: a case report"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9869-5098","authenticated-orcid":false,"given":"Tri Pudy","family":"Asmarawati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Okla Sekar","family":"Martani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bramantono","family":"Bramantono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Vitanata","family":"Arfijanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"key":"4215_CR1","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","volume":"324","author":"WJ Wiersinga","year":"2020","unstructured":"Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324:782\u201393.","journal-title":"JAMA"},{"key":"4215_CR2","unstructured":"Gugus Tugas Percepatan Penanganan COVID-19 : Peta Sebaran COVID-19 Indonesia 2021 [cited 2021 2 August 2021]. Available rom: URL|."},{"key":"4215_CR3","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1097\/CCM.0000000000004458","volume":"48","author":"T Iba","year":"2020","unstructured":"Iba T, Levy JH, Levi M, Connors JM, Thachil J. Coagulopathy of coronavirus disease 2019. Crit Care Med. 2020;48:1358\u201364.","journal-title":"Crit Care Med"},{"key":"4215_CR4","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708\u201320.","journal-title":"N Engl J Med"},{"key":"4215_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1146\/annurev-pathmechdis-012419-032640","volume":"15","author":"CA Moxon","year":"2020","unstructured":"Moxon CA, Gibbins MP, McGuinness D, Milner DA Jr, Marti M. New insights into malaria pathogenesis. Annu Rev Pathol. 2020;15:315\u201343.","journal-title":"Annu Rev Pathol"},{"key":"4215_CR6","first-page":"2020","volume-title":"20 years of global progress and challenges","author":"WHO. World Malaria Report","year":"2020","unstructured":"WHO. World Malaria Report. 20 years of global progress and challenges. Geneva: World Health Organization; 2020. p. 2020."},{"key":"4215_CR7","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.cell.2016.07.055","volume":"167","author":"AF Cowman","year":"2016","unstructured":"Cowman AF, Healer J, Marapana D, Marsh K. Malaria: biology and disease. Cell. 2016;167:610\u201324.","journal-title":"Cell"},{"key":"4215_CR8","unstructured":"Kemenkes. Kementerian Kesehatan RI. Buku Saku Tatalaksana Kasus Malaria. Jakarta: Kementerian Kesehatan RI; 2019. https:\/\/www.malaria.id\/en\/report."},{"key":"4215_CR9","unstructured":"Kemenkes. Kementerian Kesehatan RI. Profil Kesehatan Indonesia Tahun 2019. Jakarta: Kementerian Kesehatan RI; 2020. https:\/\/pusdatin.kemkes.go.id\/resources\/download\/pusdatin\/profil-kesehatan-indonesia\/Profil-Kesehatan-indonesia-2019.pdf."},{"key":"4215_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/0972-9062.234620","volume":"55","author":"KK Dayananda","year":"2018","unstructured":"Dayananda KK, Achur RN, Gowda DC. Epidemiology, drug resistance, and pathophysiology of Plasmodium vivax malaria. J Vector Borne Dis. 2018;55:1\u20138.","journal-title":"J Vector Borne Dis"},{"key":"4215_CR11","first-page":"77","volume":"12","author":"Z Shahid","year":"2021","unstructured":"Shahid Z, Karim N, Shahid F, Yousaf Z. COVID-19 associated imported Plasmodium vivax malaria relapse: first reported case and literature review. Res Rep Trop Med. 2021;12:77\u201380.","journal-title":"Res Rep Trop Med"},{"key":"4215_CR12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12936-018-2318-1","volume":"17","author":"MT White","year":"2018","unstructured":"White MT, Karl S, Koepfli C, Longley RJ, Hofmann NE, Wampfler R, et al. Plasmodium vivax and Plasmodium falciparum infection dynamics: re-infections, recrudescences and relapses. Malar J. 2018;17:170.","journal-title":"Malar J"},{"key":"4215_CR13","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/S1473-3099(13)70095-1","volume":"13","author":"GD Shanks","year":"2013","unstructured":"Shanks GD, White NJ. The activation of vivax malaria hypnozoites by infectious diseases. Lancet Infect Dis. 2013;13:900\u20136.","journal-title":"Lancet Infect Dis"},{"key":"4215_CR14","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1093\/cid\/ciy319","volume":"67","author":"CS Chu","year":"2018","unstructured":"Chu CS, Phyo AP, Lwin KM, Win HH, San T, Aung AA, et al. Comparison of the cumulative efficacy and safety of chloroquine, artesunate, and chloroquine-primaquine in Plasmodium vivax malaria. Clin Infect Dis. 2018;67:1543\u20139.","journal-title":"Clin Infect Dis"},{"key":"4215_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000514254","volume":"4","author":"MM Eid","year":"2021","unstructured":"Eid MM. Co-Infection with COVID-19 and malaria in a young man. Dubai Med J. 2021;4:1\u20133.","journal-title":"Dubai Med J"},{"key":"4215_CR16","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s12098-020-03441-6","volume":"87","author":"R Kishore","year":"2020","unstructured":"Kishore R, Dhakad S, Arif N, Dar L, Mirdha BR, Aggarwal R, et al. COVID-19: possible cause of induction of relapse of Plasmodium vivax Infection. Indian J Pediatr. 2020;87:751\u20132.","journal-title":"Indian J Pediatr"},{"key":"4215_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2020.e00879","volume":"21","author":"S Sardar","year":"2020","unstructured":"Sardar S, Sharma R, Alyamani TYM, Aboukamar M. COVID-19 and Plasmodium vivax malaria co-infection. IDCases. 2020;21: e00879.","journal-title":"IDCases"},{"key":"4215_CR18","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1093\/cid\/ciaa351","volume":"71","author":"K Xu","year":"2020","unstructured":"Xu K, Chen Y, Yuan J, Yi P, Ding C, Wu W, et al. Factors associated with prolonged viral RNA shedding in patients with coronavirus disease 2019 (COVID-19). Clin Infect Dis. 2020;71:799\u2013806.","journal-title":"Clin Infect Dis"},{"key":"4215_CR19","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.ijid.2021.02.117","volume":"105","author":"A Mondi","year":"2021","unstructured":"Mondi A, Lorenzini P, Castilletti C, Gagliardini R, Lalle E, Corpolongo A, et al. Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital. Int J Infect Dis. 2021;105:532\u20139.","journal-title":"Int J Infect Dis"},{"key":"4215_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108611","volume":"221","author":"C Gao","year":"2020","unstructured":"Gao C, Zhu L, Jin CC, Tong YX, Xiao AT, Zhang S. Proinflammatory cytokines are associated with prolonged viral RNA shedding in COVID-19 patients. Clin Immunol (Orlando, Fla). 2020;221: 108611. https:\/\/doi.org\/10.1016\/j.clim.2020.108611.","journal-title":"Clin Immunol (Orlando, Fla)"},{"key":"4215_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108611","volume":"221","author":"C Gao","year":"2020","unstructured":"Gao C, Zhu L, Jin CC, Tong YX, Xiao AT, Zhang S. Proinflammatory cytokines are associated with prolonged viral RNA shedding in COVID-19 patients. Clin Immunol. 2020;221: 108611.","journal-title":"Clin Immunol"},{"key":"4215_CR22","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1002\/ajh.25829","volume":"95","author":"E Terpos","year":"2020","unstructured":"Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020;95:834\u201347.","journal-title":"Am J Hematol"},{"key":"4215_CR23","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s12185-021-03084-z","volume":"113","author":"H Mori","year":"2021","unstructured":"Mori H, Ohkawara H, Togawa R, Rikimaru M, Shibata Y, Ikezoe T. Diagnosis and treatment of disseminated intravascular coagulation in COVID-19 patients: a scoping review. Int J Hematol. 2021;113:320\u20139.","journal-title":"Int J Hematol"},{"key":"4215_CR24","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/jmv.26346","volume":"93","author":"J Lin","year":"2021","unstructured":"Lin J, Yan H, Chen H, He C, Lin C, He H, et al. COVID-19 and coagulation dysfunction in adults: a systematic review and meta-analysis. J Med Virol. 2021;93:934\u201344.","journal-title":"J Med Virol"},{"key":"4215_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/10739680701451516","volume":"15","author":"IM Francischetti","year":"2008","unstructured":"Francischetti IM, Seydel KB, Monteiro RQ. Blood coagulation, inflammation, and malaria. Microcirculation. 2008;15:81\u2013107.","journal-title":"Microcirculation"},{"key":"4215_CR26","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2012.061","volume":"4","author":"B Autino","year":"2012","unstructured":"Autino B, Corbett Y, Castelli F, Taramelli D. Pathogenesis of malaria in tissues and blood. Mediterr J Hematol Infect Dis. 2012;4: e2012061.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"4215_CR27","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4103\/jgid.jgid_160_20","volume":"12","author":"M Ray","year":"2020","unstructured":"Ray M, Vazifdar A, Shivaprakash S. Co-infection with malaria and coronavirus disease-2019. J Glob Infect Dis. 2020;12:162\u20133.","journal-title":"J Glob Infect Dis"},{"key":"4215_CR28","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1186\/s12879-021-06164-x","volume":"21","author":"T Manabe","year":"2021","unstructured":"Manabe T, Kambayashi D, Akatsu H, Kudo K. Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis. BMC Infect Dis. 2021;21:489.","journal-title":"BMC Infect Dis"},{"key":"4215_CR29","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1134\/S0026893321040105","volume":"55","author":"AA Zenchenko","year":"2021","unstructured":"Zenchenko AA, Drenichev MS, Il\u2019icheva IA, Mikhailov SN. Antiviral and antimicrobial nucleoside derivatives: structural features and mechanisms of action. Mol Biol. 2021;55:786\u2013812.","journal-title":"Mol Biol"},{"key":"4215_CR30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13020-020-00336-8","volume":"15","author":"T Uzun","year":"2020","unstructured":"Uzun T, Toptas O. Artesunate: could be an alternative drug to chloroquine in COVID-19 treatment? Chin Med. 2020;15:54.","journal-title":"Chin Med"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04215-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-022-04215-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04215-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T14:08:17Z","timestamp":1655993297000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-022-04215-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,23]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4215"],"URL":"https:\/\/doi.org\/10.1186\/s12936-022-04215-5","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,23]]},"assertion":[{"value":"14 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details and\/or clinical images was obtained from the patient. A copy of the consent form is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"199"}}